Net Cash Provided by (Used in) Investing Activities in USD of AEON Biopharma, Inc. from Q1 2021 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
AEON Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and change rate from Q1 2021 to Q1 2025.
  • AEON Biopharma, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2025 was -$4K.
  • AEON Biopharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$306K, a 99.9% increase from 2021.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Change (%)

AEON Biopharma, Inc. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$4K* Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q1 2023 $260M +$260M Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-17
Q1 2022 $80.5K* +$276M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-17
Q1 2021 -$276M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12

AEON Biopharma, Inc. Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$306K +$276M +99.9% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
2021 -$276M Jan 1, 2021 Dec 31, 2021 10-K/A 2023-04-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.